Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Gefitinib therapy can cause unusual hair growth on the nose.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Mathematical modeling helps understand and predict the MAPK cell signaling pathway.

Piperonylic acid speeds up wound healing by reducing inflammation and boosting collagen.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Lupeol shows promise for hair growth but needs better absorption and safety testing.

Isaria cicadae Miquel rice fermentation extract helps heal wounds and regenerate hair follicles.

Baicalin may help treat hair loss by promoting hair follicle growth and activating specific cellular pathways.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

EREG therapy may help treat hair loss by promoting hair growth.

Endogenous EGF helps heal second-degree scald wounds faster.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Inhibiting certain proteins harms hair follicle immunity and increases IL-33, affecting hair health.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

A protein called desmoglein 3 is important for keeping hair follicle stem cells inactive and helps in their regeneration.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.